Genolution Inc. (KOSDAQ: A225220)
Health Care · Life Sciences Tools & Services · KR
₩1,444.00
-1.70% today · -34.4% 1Y
Genolution Inc. (KOSDAQ: A225220) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $19.41M.
Over the last twelve months the share price has lost 34.4%, trading between 957.00 and 2.33K.
Tweenvest scores Genolution Inc. across four factors: quality 56/100, value 69/100, growth 0/100. Its strongest factor is value.
A225220 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $19.41M
- Revenue (TTM)
- $6.48M
- P/E
- —
- EPS
- -257.72
- Dividend yield
- —
- Beta (5Y)
- 0.13
- 52-week high
- ₩2,330.00
- 52-week low
- ₩957.00
- Avg volume (3M)
- —
- Shares outstanding
- 18.07M
- Employees
- —
- Next earnings
- —
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Human Metabolome Technologies, Inc.TSE: 6090 | $21.22M | ¥604.00 | -0.33% |
| atect corporationTSE: 4241 | $20.21M | ¥724.00 | +1.54% |
| C&R Research Inc.KOSDAQ: A359090 | $19.88M | ₩2,325.00 | +1.97% |
| SLS BIO Co., LtdKOSDAQ: A246250 | $19.85M | ₩— | — |
| Promimic AB (publ)OM: PRO | $18.42M | Skr9.60 | -1.54% |
| OncoSil Medical LimitedASX: OSL | $17.93M | AU$0.70 | -11.39% |
| Oxford BioDynamics PlcAIM: OBD | $17.79M | £0.00 | -13.04% |
| Veritas In Silico Inc.TSE: 130A | $17.45M | ¥426.00 | -1.84% |
Figures last refreshed Oct 11, 2026.